Munich, Germany

Alexander Haas

USPTO Granted Patents = 12 

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 41(Granted Patents)


Location History:

  • Weilheim, DE (2022)
  • Munich, DE (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
12 patents (USPTO):

Title: Discovering the Innovations of Alexander Haas

Introduction

Alexander Haas, an esteemed inventor based in Munich, Germany, has made significant contributions to the field of biotechnology with a remarkable portfolio of 11 patents. His notable work primarily focuses on the development of novel antibodies, which hold great potential for therapeutic applications.

Latest Patents

Haas's latest patents include groundbreaking inventions such as bispecific 2+1 contorsbodies. This invention relates to novel bispecific antibodies that consist of two fusion polypeptides incorporating two antigen-binding domains capable of specific binding to a first target, along with one antigen-binding domain specific to a second target. Additionally, he has developed humanized anti-human CD19 antibodies, which are designed to bind specifically to human CD19. This antibody comprises multiple highly variable regions (HVR) with specific amino acid sequences, providing innovative solutions for targeting this critical antigen in human therapeutics.

Career Highlights

Alexander Haas is currently employed at Hoffmann-La Roche Inc., where he collaborates on various research initiatives aimed at advancing drug development. His extensive background in biotechnology research has equipped him with the skills necessary to drive forward the frontiers of therapeutic innovation.

Collaborations

Haas works alongside talented colleagues such as Guy Georges and Ulrich Brinkmann. This dynamic collaboration fosters an environment of creative synergy, enhancing the potential for developing groundbreaking solutions within their field.

Conclusion

In conclusion, Alexander Haas stands out as a prominent inventor in the biotechnology landscape, with his innovative patents playing a crucial role in the advancement of targeted therapies. His work at Hoffmann-La Roche Inc., coupled with fruitful collaborations, continues to drive forward the progress of scientific discovery and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…